logo
#

Latest news with #DurgeshNandanJha

Monitor NDMA levels in antacid Ranitidine: Drugs body CDSCO
Monitor NDMA levels in antacid Ranitidine: Drugs body CDSCO

Time of India

timea day ago

  • Health
  • Time of India

Monitor NDMA levels in antacid Ranitidine: Drugs body CDSCO

NEW DELHI: Drug controllers of all states and UTs have been asked by Central Drugs Standard Control Organisation (CDSCO) to direct manufacturers under their jurisdiction to monitor levels of NDMA in the active pharmaceutical ingredient or drug formulation of Ranitidine, a commonly used antacid. NDMA (N-nitrosodimethylamine) is a chemical which has been recognised as a probable carcinogen by International Agency for Research on Cancer (IARC), reports Durgesh Nandan Jha. CDSCO's decision came after reports of NDMA impurity in the medicine. An expert panel was appointed to deliberate on the concern in Dec last year. Sources said the the committee's recommendations were deliberated in a meeting of Drug Technical Advisory Body recently. DTAB recommended that a larger committee be constituted to look into all aspects, including storage conditions of Ranitidine, and also suggested that the Indian Council of Medical Research undertake a study to assess the drug's safety in addition to directing manufacturers to monitor NDMA levels in the drug and, if required, take risk-based measures such as reducing the shelf life.

Why more Indians are ditching costly medicines — and trusting generics
Why more Indians are ditching costly medicines — and trusting generics

Time of India

time27-06-2025

  • Health
  • Time of India

Why more Indians are ditching costly medicines — and trusting generics

Why more Indians are ditching costly medicines — and trusting generics Durgesh Nandan Jha TNN Jun 27, 2025, 14:56 IST IST Once dismissed as unreliable, govt-supplied generic medicines are gaining traction — thanks to soaring medical costs, expanding Jan Aushadhi stores, and a slow but steady shift in public trust Manikant Thakur and his wife, who have diabetes and hypertension, used to spend nearly Rs 2,000 a month on medicines until last year. But then, in December, Thakur lost his job and, to cut expenses until he could find a new job, he decided to switch to generic drugs supplied from the Jan Aushadhi store. These were 50%-80% cheaper than the branded generics he had been using earlier. 'We went against the advice of our family doctor, who said the generic medicines supplied at Jan Aushadhi stores weren't of good quality, which is why they were cheap,' Thakur says. 'But we still wanted to give it a shot, as every single penny counted.'

Covid is back in the news. What you need to know about the latest wave
Covid is back in the news. What you need to know about the latest wave

Time of India

time27-05-2025

  • Health
  • Time of India

Covid is back in the news. What you need to know about the latest wave

Covid is back in the news. What you need to know about the latest wave Durgesh Nandan Jha TNN May 27, 2025, 14:27 IST IST Reports of Covid-19 cases are trickling in from across India. Some Southeast Asian countries are also witnessing a recurrence. Why there's no need to panic Reports of Covid-19 cases are trickling in from across India. Some Southeast Asian countries are also witnessing a recurrence.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store